The human O-GlcNAcome database and meta-analysis E Wulff-Fuentes, RR Berendt, L Massman, L Danner, F Malard, J Vora, ... Scientific data 8 (1), 25, 2021 | 184 | 2021 |
Principles and correction of 5’-splice site selection F Malard, CD Mackereth, S Campagne RNA biology 19 (1), 943-960, 2022 | 17 | 2022 |
An in vitro reconstituted U1 snRNP allows the study of the disordered regions of the particle and the interactions with proteins and ligands S Campagne, T de Vries, F Malard, P Afanasyev, G Dorn, E Dedic, ... Nucleic acids research 49 (11), e63-e63, 2021 | 15 | 2021 |
Structural insights into TCTP and its interactions with ligands and proteins N Assrir, F Malard, E Lescop TCTP/tpt1-Remodeling Signaling from Stem Cell to Disease, 9-46, 2017 | 11 | 2017 |
Automatization and self-maintenance of the O-GlcNAcome catalog: a smart scientific database F Malard, E Wulff-Fuentes, RR Berendt, G Didier, S Olivier-Van Stichelen Database 2021, baab039, 2021 | 10 | 2021 |
Conformational ensemble and biological role of the TCTP intrinsically disordered region: influence of calcium and phosphorylation F Malard, N Assrir, M Alami, S Messaoudi, E Lescop, T Ha-Duong Journal of molecular biology 430 (11), 1621-1639, 2018 | 10 | 2018 |
Molecular basis of RNA-binding and autoregulation by the cancer-associated splicing factor RBM39 S Campagne, D Jutzi, F Malard, M Matoga, K Romane, M Feldmuller, ... Nature communications 14 (1), 5366, 2023 | 8 | 2023 |
Revisiting the molecular interactions between the tumor protein TCTP and the drugs sertraline/thioridazine F Malard, E Jacquet, N Nhiri, C Sizun, A Chabrier, S Messaoudi, J Dejeu, ... ChemMedChem 17 (1), e202100528, 2022 | 8 | 2022 |
Drimane Derivatives as the First Examples of Covalent BH3 Mimetics that Target MCL‐1 F Daressy, F Malard, L Seguy, V Guérineau, C Apel, V Dumontet, ... ChemMedChem 16 (11), 1789-1798, 2021 | 7 | 2021 |
The diversity of splicing modifiers acting on A-1 bulged 5′-splice sites reveals rules for rational drug design F Malard, AC Wolter, J Marquevielle, E Morvan, A Ecoutin, SH Rüdisser, ... Nucleic Acids Research 52 (8), 4124-4136, 2024 | 5 | 2024 |
Studying the O-GlcNAcome of human placentas using banked tissue samples S Luna, F Malard, M Pereckas, M Aoki, K Aoki, S Olivier-Van Stichelen Glycobiology 34 (4), cwae005, 2024 | 4 | 2024 |
Non-Nutritive Sweeteners Acesulfame Potassium and Sucralose Are Competitive Inhibitors of the Human P-glycoprotein/Multidrug Resistance Protein 1 (PGP/MDR1) L Danner, F Malard, R Valdes, S Olivier-Van Stichelen Nutrients 15 (5), 1118, 2023 | 4 | 2023 |
Find out if your protein is O‐GlcNAc modified: The O‐GlcNAc database S Olivier‐Van Stichelen, F Malard, R Berendt, E Wulff‐Fuentes, L Danner The FASEB Journal 36, 2022 | 4 | 2022 |
EpyNN: Educational python for Neural Networks F Malard, L Danner, E Rouzies, JG Meyer, E Lescop, ... SoftwareX 19, 101140, 2022 | 2 | 2022 |
Molecular Basis for the Calcium-Dependent Activation of the Ribonuclease EndoU F Malard, K Dias, M Baudy, S Thore, B Vialet, P Barthélémy, S Fribourg, ... | 1 | 2024 |
Small molecules modulating RNA splicing: a review of targets and future perspectives L Bouton, A Ecoutin, F Malard, S Campagne RSC Medicinal Chemistry, 2024 | 1 | 2024 |
Structural transitions in TCTP tumor protein upon binding to the anti-apoptotic protein family member Mcl-1 F Malard, C Sizun, A Thureau, L Carlier, E Lescop Journal of Biological Chemistry 299 (7), 2023 | 1 | 2023 |
The O-GlcNAc database: introducing new features and tools developed from community feedback F Malard, L Massman, S Campagne, S Olivier-Van Stichelen Analytical and Bioanalytical Chemistry, 1-6, 2024 | | 2024 |
1H, 13C and 15N backbone resonance assignment of the calcium-activated EndoU endoribonuclease F Malard, FV Karginov, S Campagne Biomolecular NMR Assignments, 1-5, 2024 | | 2024 |
Unintentional family poisoning with a chocolate bar with Psilocybe cubensis inside: a case report C Adamski, JA Vaucel, C Paradis, C Brunet, A Nardon, A Courtois, ... Toxicologie Analytique et Clinique, 2023 | | 2023 |